Protocol
Mazdutide (5mg Vial)
Complete dosage protocol and reconstitution guide for Mazdutide (5mg Vial).
Calculator preset
Run the vial math before tracking.
At ~1.67 mg/mL, 1 unit ~ 16.7 mcg ; 2.5 mg ~ 150 units and 5 mg ~ 300 units on a U-100 syringe.
01 · At a glance
Quickstart Highlights
Mazdutide (IBI362) is a long‑acting dual GLP‑1/glucagon receptor agonist developed for chronic weight management and type 2 diabetes. [1] [2] Phase 2 and 3 clinical trials have demonstrated substantial weight loss (6–14% reduction over 24–48 weeks) with mostly mild gastrointestinal side effects. [2] [3] [5] This educational protocol presents a once‑weekly subcutaneous approach with practical dilution for clear insulin‑syringe measurements.
02 · Dosing & reconstitution
Dosing & Reconstitution Guide
A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.
Standard / Gradual Titration (3.0 mL = ~1.67 mg/mL)
2.5–6 mg once weekly with gradual titration.
Advanced / Aggressive Approach
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl until dissolved (do not shake vigorously).
- Label with date and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.
03 · What you'll need
Supplies Needed
Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.
- 12 weeks ≈ 10 vials (Weeks 1–4: 2 vials; Weeks 5–12: 8 vials)
- 16 weeks ≈ 14 vials (Weeks 1–4: 2 vials; Weeks 5–16: 12 vials)
- 8 weeks: 8 syringes
- 12 weeks: 12 syringes
- 16 weeks: 16 syringes
- 8 weeks (6 vials): 18 mL → 2 × 10 mL bottles
- 12 weeks (10 vials): 30 mL → 3 × 10 mL bottles
- 16 weeks (14 vials): 42 mL → 5 × 10 mL bottles
- Per week: 2 swabs
- 8 weeks: 16 swabs → recommend 1 × 100‑count box
- 12 weeks: 24 swabs → recommend 1 × 100‑count box
- 16 weeks: 32 swabs → recommend 1 × 100‑count box
Protocol Overview
- Goal: Support chronic weight management and metabolic improvement through dual GLP‑1/glucagon receptor activation. [2] [3]
- Schedule: Once‑weekly subcutaneous injections for 8–12 weeks minimum (clinical trials ranged from 12–48 weeks).
- Dose Range: 2.5–6 mg weekly with gradual titration; advanced protocols may reach 10 mg.
- Reconstitution: 3.0 mL per 5 mg vial (~1.67 mg/mL) for standard dosing; 2.0 mL for higher concentrations if needed.
- Storage: Lyophilized frozen at −20 °C (−4 °F); reconstituted refrigerated at 2–8 °C (35.6–46.4 °F); discard after 28 days. [7] [9]
Dosing Protocol
- Suggested weekly titration approach.
- Start: 2.5 mg once weekly for first 4 weeks to establish tolerability.
- Increase: Advance to 5 mg weekly at week 5; maintain for remainder of protocol (weeks 5–12+).
- Frequency: Once per week (subcutaneous injection).
- Cycle Length: Minimum 8 weeks; clinical evidence supports 12–48 week protocols.
- Timing: Administer on the same day each week; rotate injection sites to avoid irritation.
Storage Instructions
- Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; avoid freeze–thaw cycles. [7]
- Storage: Lyophilized frozen at −20 °C (−4 °F); reconstituted refrigerated at 2–8 °C (35.6–46.4 °F); discard after 28 days. [7] [9]
- Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.
04 · Good to know
Important Notes
- This Mazdutide page is for educational research organization only.
- Confirm route, dose, contraindications, monitoring, storage, and cycle decisions with qualified professional guidance.
- Use sterile technique, rotate sites when applicable, and log missed doses, reactions, and inventory changes.
05 · How it works
How This Works
Mazdutide (IBI362) is a long‑acting dual GLP‑1/glucagon receptor agonist developed for chronic weight management and type 2 diabetes. [1] [2] Phase 2 and 3 clinical trials have demonstrated substantial weight loss (6–14% reduction over 24–48 weeks) with mostly mild gastrointestinal side effects. [2] [3] [5] This educational protocol presents a once‑weekly...
Reconstitute: Add 3.0 mL bacteriostatic water → ~ 1.67 mg/mL concentration (standard protocol).
Typical weekly range: 2.5–6 mg once weekly with gradual titration.
The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.
06 · Daily habits
Lifestyle Factors
- Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
- Track body metrics only if they are relevant to the user's goal and approved data sources.
- Use consistent timing and logging habits so adherence data is meaningful.
07 · What to expect
Potential Benefits & Side Effects
- Mazdutide observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
- This section is not a claim of therapeutic benefit.
08 · Technique
Injection Technique
- Wash hands with soap and water.
- Wipe the vial stopper and chosen site with alcohol, then let both dry.
- Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
- Use the route and needle technique directed by a qualified professional or product instructions.
- For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
- Do not reuse needles or syringes.
- Dispose of sharps in a puncture-resistant container.
- Return stored items promptly to the correct temperature.
- Log dose, site, date, time, inventory change, and any observation.
09 · Evidence
References
Related pages